Alirocumab: A New Cholesterol Lowering Drug Received FDA Advisory Panel Approval
US FDA advisory panel has suggested the approval of a new, injectable cholesterol-lowering drug known as alirocumab, though many panel
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine